PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportssubstance withdrawal syndrome
MeSH D013375 - substance withdrawal syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019966:Substance-related disorders
10 Companies
2 Drugs
$
Success rate
D013375: 
Substance withdrawal syndrome
117 Companies
15 Drugs
$
Success rate
D000430:Alcohol withdrawal delirium
62 Companies
8 Drugs
$
Success rate
D020270:Alcohol withdrawal seizures
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClonidine Clonidine  1986-07-08   
Novast LaboratoriesClonidine Clonidine  2019-03-05   
MylanClonidine Clonidine  2010-07-16   
Clonidine Duraclon  1996-10-02   
NATCO PharmaClonidine, Chlorthalidone Clorpres  1987-02-09   
Chartwell PharmaceuticalsClonidine Clonidine  2017-10-23   
Lorazepam Lorazepam  1987-10-13   
Lupin ResearchLorazepam Lorazepam  2013-02-19   
SandozLorazepam Lorazepam  1987-04-21   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
50%
2/4
Phase 2
29%
2/7
Phase 3
69%
11/16
Approved: 10Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Amitriptyline,
Haloperidol,
Haloperidol decanoate
Mylan
Haloperidol,
Haloperidol decanoate
Johnson & Johnson
Haloperidol,
Haloperidol decanoate
Sandoz
Haloperidol decanoate
Boehringer Ingelheim
Clonidine
Novartis
Carbamazepine
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use